Patient Name : KHUSHBU Barcode : B0788059

Age/Gender : 24Y 0M 0D /Female Sample Collected On : 02/Jan/2025 12:26PM

Order Id : 12451552904 Sample Received On : 02/Jan/2025 01:38PM
Referred By : SELF Report Generated On : 02/Jan/2025 02:41PM
Customer Since : 02/Jan/2025 Sample Temperature : Maintained
Sample Type : Whole Blood EDTA Report Status : Final Report

DEPARTMENT OF HAEMATOLOGY
Test Name Value Unit Bio. Ref Interval

Complete Haemogram
Haemoglobin (HB) 13.5 g/dL 12.0-15.0
Method: Photometry
Total Leucocyte Count (TLC) 8.4 10^3/uL 4.0-10.0
Method: Impedance
Hematocrit (PCV) 39.4 % 36.0-46.0
Method: Calculated
Red Blood Cell Count (RBC) 5.00 10^6/µl 3.80-4.80
Method: Impedance
Mean Corp Volume (MCV) 78.8 fL 83.0-101.0
Method: Derived from RBC Histogram
Mean Corp Hb (MCH) 27 pg 27.0-32.0
Method: Calculated
Mean Corp Hb Conc (MCHC) 34.3 g/dL 31.5-34.5
Method: Calculated
RDW - CV 12.4 % 11.6-14.0
Method: Derived from RBC Histogram
RDW - SD 39.90 fL 39.0-46.0
Method: Derived from RBC Histogram
Mentzer Index 15.76 Ratio
Method: Calculated
RDWI 195.42 Ratio
Method: Calculated
Green and king index 57 Ratio
Method: Calculated
Differential Leucocyte Count
Neutrophils 54.8 % 40 - 80
Method: VCS Technology
Lymphocytes 35.2 % 20-40
Method: VCS Technology
Monocytes 6.2 % 02 - 10
Method: VCS Technology
Eosinophils 3.3 % 01 - 06
Method: VCS Technology

Page 1 of 3
SIN No:B0788059
 Patient Name : KHUSHBU Barcode : B0788059
Age/Gender : 24Y 0M 0D /Female Sample Collected On : 02/Jan/2025 12:26PM
Order Id : 12451552904 Sample Received On : 02/Jan/2025 01:38PM
Referred By : SELF Report Generated On : 02/Jan/2025 02:41PM
Customer Since : 02/Jan/2025 Sample Temperature : Maintained
Sample Type : Whole Blood EDTA Report Status : Final Report

DEPARTMENT OF HAEMATOLOGY
Test Name Value Unit Bio. Ref Interval

Basophils 0.5 % 00 - 02
Method: VCS Technology
Absolute Leucocyte Count
Absolute Neutrophil Count (ANC) 4.62 10^3/uL 2.0-7.0
Method: Calculated
Absolute Lymphocyte Count (ALC) 2.97 10^3/uL 1.0-3.0
Method: Calculated
Absolute Monocyte Count 0.52 10^3/uL 0.2-1.0
Method: Calculated
Absolute Eosinophil Count (AEC) 0.28 10^3/uL 0.02-0.5
Method: Calculated
Absolute Basophil Count 0.04 10^3/uL 0.02 - 0.10
Method: Calculated
Platelet Count(PLT) 315 10^3/µl 150-410
Method: Impedance
PDW 14.8 % 9.6 - 15.2
MPV 10.3 fL 7-9
Method: Derived from PLT Histogram
PCT 0.32 % 0.19 - 0.39
ESR 12 mm/1st hour 0-12
Method: Modified Westergren Method
The International Council for Standardization in Haematology (ICSH) recommends reporting of absolute counts of various WBC subsets for clinical decision making.
This test has been performed on a fully automated 5 part differential cell counter which counts over 10,000 WBCs to derive differential counts. A complete blood
count is a blood panel that gives information about the cells in a patient's blood, such as the cell count for each cell type and the concentrations of Hemoglobin and
platelets. The cells that circulate in the bloodstream are generally divided into three types: white blood cells (leukocytes), red blood cells (erythrocytes), and platelets
(thrombocytes). Abnormally high or low counts may be physiological or may indicate disease conditions, and hence need to be interpreted clinically.

The Mentzer index is used to differentiate iron deficiency anaemia beta thalassemia trait. If a CBC indicates microcytic anaemia, these are two of the most likely
causes, making It necessary to distinguish between them.
If the quotient of the mean corpuscular volume divided by the red blood cell count is then 13, thalassemia is more likely. If the result is greater than 13, then iron-
deficiency anaemia is more likely. Green and King Index used to differentiate IDA from thalassemia trait value >65 is likely to be Iron Deficiency Anemiaand value <65
Beta Thalassemia Trait. For RDWI Value >220 more likely to be Iron Deficiency Anemia and value <220 more likely to be Beta Thalassemia Trait .

ESR is a non-specific phenomenon, its measurement is clinically useful in disorders associated with an increased production of acute-phase proteins. it provides an
index of progress of the disease in rheumatoid arthritis or tuberculosis, and it is of considerable value in diagnosis of temporal arteritis and polymyalgia rheumatica. It
is often used if multiple myeloma is suspected, but when the myeloma is non-secretory or light chain, a normal ESR does not exclude this diagnosis.

An elevated ESR occurs as an early feature in myocardial infarction. Although a normal ESR cannot be taken to exclude the presence of organic disease, the vast
majority of acute or chronic infections and most neoplastic and degenerative diseases are associated with changes in the plasma proteins that increased ES values.
An increased ESR in subjects who are HIV seropositive seems to be an early predictive marker of progression toward acquired immune deficiency syndrome

Page 2 of 3
SIN No:B0788059
 Patient Name : KHUSHBU Barcode : B0788059
Age/Gender : 24Y 0M 0D /Female Sample Collected On : 02/Jan/2025 12:26PM
Order Id : 12451552904 Sample Received On : 02/Jan/2025 01:38PM
Referred By : SELF Report Generated On : 02/Jan/2025 02:41PM
Customer Since : 02/Jan/2025 Sample Temperature : Maintained
Sample Type : Whole Blood EDTA Report Status : Final Report

DEPARTMENT OF HAEMATOLOGY
Test Name Value Unit Bio. Ref Interval

(AIDS).
The ESR is influenced by age, stage of the menstrual cycle and medications taken (corticosteroids, contraceptive pills). It is especially low (0–1 mm) in
polycythaemia, hypofibrinogenaemia and congestive cardiac failure and when there are abnormalities of the red cells such as poikilocytosis, spherocytosis, or sickle
cells.
In cases of performance enhancing drug intake by athletes the ESR values are generally lower than the usual value for the individual and as a result of the
increase in haemoglobin (i.e. the effect of secondary polycythaemia).

*** End Of Report ***

Page 3 of 3
SIN No:B0788059